Cosmos Health targets 2029 revenue USD 200.6 million, net income USD 31 million
Bitget2026/09/29 13:30- Cosmos Health issued 2029 guidance for revenue of USD 200.6 million, gross profit of USD 71.2 million, adjusted EBITDA of USD 44.2 million.
- Outlook also targets 2029 net income of USD 31.0 million, with CosmoFarm expected to be central to volume growth.
- CosmoFarm posted Q2 2026 revenue above USD 15 million, implying an annualized run-rate above USD 60 million.
- Automation expansion is expected to support more than USD 40 million of additional annual revenue capacity, positioning CosmoFarm above USD 100 million annualized.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barrick’s Marquee gold project faces hazy study timing
Japanese and South Korean stock markets open
Marvell Technology (MRVL.US) $115 billion "merger of the century" faces lukewarm reception! Stock has dropped over 40%, experts estimate only a 50% chance of completion
Marvell plans to acquire Lamington for 115 billions USD to strengthen its position in AI, but the probability of completion is only 50%. The two stocks have dropped by nearly 40% and about 35% respectively, with Chinese regulatory approval being the biggest uncertainty.
Crypto prices
More
